Is Shandong Keyuan Pharmaceutical Co Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Shandong Keyuan Pharmaceutical Co Ltd (301281.SZ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Shandong Keyuan Pharmaceutical Co Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Shandong Keyuan Pharmaceutical Co Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Shandong Keyuan Pharmaceutical Co Ltd?

Muslim investors may consider investing in Shandong Keyuan Pharmaceutical Co Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Shandong Keyuan Pharmaceutical Co Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Shandong Keyuan Pharmaceutical Co Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Shandong Keyuan Pharmaceutical Co Ltd updated?

The Shariah compliance status of Shandong Keyuan Pharmaceutical Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Shandong Keyuan Pharmaceutical Co Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Shandong Keyuan Pharmaceutical Co Ltd?

You can check the latest Shariah compliance status of Shandong Keyuan Pharmaceutical Co Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Shandong Keyuan Pharmaceutical Co Ltd 301281.SZ

Last Updated: May 15, 12:00 AM·SZSE

Shandong Keyuan Pharmaceutical Co Ltd. Stock Analysis 301281.SZ

China Health Care Small Cap

Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. The company is headquartered in Jinan, Shandong and currently employs 650 full-time employees. The company went IPO on 2023-04-04. The main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and isosorbide mononitrate. The products are used in the treatment of hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The firm also customizes chemical intermediates according to customer needs. The products are sold in both domestic and overseas markets.

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.

I accept the above